Connect Biopharma is trading 5.5% up at $2.13 in pre-market, extending the rebound seen late last week.
- The move appears driven by supportive macro sentiment and higher U.S. index futures rather than new company-specific fundamentals or catalysts.
- Recent gains are aligned with a general risk-on environment and broader market strength, alongside continued speculative interest.